Akinetic‐rigid and tremor‐dominant Parkinson's disease patients show different patterns of FP‐CIT Single photon emission computed tomography

To elucidate whether Parkinson's disease subtypes show a different pattern of Iodine‐123 fluoropropyl–;carbomethoxy‐3 β‐(FP‐CIT) single photon emission computed tomography (SPECT) binding in accordance with neuropathological findings.

[1]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[2]  Kevin Wilson,et al.  Shape analysis of 123I-N-ω-fluoropropyl-2-&bgr;-carbomethoxy-3&bgr;-(4-iodophenyl) nortropane single-photon emission computed tomography images in the assessment of patients with parkinsonian syndromes , 2009, Nuclear medicine communications.

[3]  O. Hornykiewicz,et al.  Globus pallidus dopamine and Parkinson motor subtypes , 2008, Neurology.

[4]  Wim Vandenberghe,et al.  The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Yann Cointepas,et al.  Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images , 2007, Journal of Nuclear Medicine.

[6]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[7]  U. Dillmann,et al.  Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease , 2007, Journal of Neural Transmission.

[8]  S. Breit,et al.  [(11)C]d-threo-methylphenidate PET in patients with Parkinson's disease and essential tremor. , 2006, Journal of neural transmission.

[9]  S. Breit,et al.  [11C]d-threo-methylphenidate PET in patients with Parkinson’s disease and essential tremor , 2006, Journal of Neural Transmission.

[10]  Rosemary J Morton,et al.  Comparison of different methods of DatSCAN quantification , 2005, Nuclear medicine communications.

[11]  Perry E Radau,et al.  Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  T. Robbins,et al.  Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  H. Freund,et al.  The cerebral oscillatory network of parkinsonian resting tremor. , 2003, Brain : a journal of neurology.

[14]  P. Rochon,et al.  Predicting motor decline and disability in Parkinson disease: a systematic review. , 2002, Archives of neurology.

[15]  A Pupi,et al.  European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands. , 2002, European journal of nuclear medicine and molecular imaging.

[16]  J. Jankovic,et al.  Functional decline in Parkinson disease. , 2001, Archives of neurology.

[17]  S. Gacinovic,et al.  Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group , 2000, Movement disorders : official journal of the Movement Disorder Society.

[18]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[19]  K. Jellinger.  Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms? , 1999, Journal of neural transmission. Supplementum.

[20]  Marc Laruelle,et al.  SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates , 1993, Synapse.

[21]  P. Thompson,et al.  Isolated tremor and disruption of the nigrostriatal dopaminergic system , 1992, Neurology.

[22]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[23]  M. Kaufman,et al.  Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum , 1991, Synapse.

[24]  P. Seeman,et al.  The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus , 1991, Journal of neurochemistry.

[25]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .